These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 17366323)

  • 1. Inhibition of ALK5 signaling induces physeal dysplasia in rats.
    Frazier K; Thomas R; Scicchitano M; Mirabile R; Boyce R; Zimmerman D; Grygielko E; Nold J; DeGouville AC; Huet S; Laping N; Gellibert F
    Toxicol Pathol; 2007 Feb; 35(2):284-95. PubMed ID: 17366323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase in ALK1/ALK5 ratio as a cause for elevated MMP-13 expression in osteoarthritis in humans and mice.
    Blaney Davidson EN; Remst DF; Vitters EL; van Beuningen HM; Blom AB; Goumans MJ; van den Berg WB; van der Kraan PM
    J Immunol; 2009 Jun; 182(12):7937-45. PubMed ID: 19494318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors.
    Goumans MJ; Valdimarsdottir G; Itoh S; Rosendahl A; Sideras P; ten Dijke P
    EMBO J; 2002 Apr; 21(7):1743-53. PubMed ID: 11927558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
    Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
    Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of activin receptor-like kinase 5 attenuates bleomycin-induced pulmonary fibrosis.
    Higashiyama H; Yoshimoto D; Kaise T; Matsubara S; Fujiwara M; Kikkawa H; Asano S; Kinoshita M
    Exp Mol Pathol; 2007 Aug; 83(1):39-46. PubMed ID: 17274978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profiling demonstrates that TGF-beta1 signals exclusively through receptor complexes involving Alk5 and identifies targets of TGF-beta signaling.
    Karlsson G; Liu Y; Larsson J; Goumans MJ; Lee JS; Thorgeirsson SS; Ringnér M; Karlsson S
    Physiol Genomics; 2005 May; 21(3):396-403. PubMed ID: 15769904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct regulation of gene expression in human endothelial cells by TGF-beta and its receptors.
    Wu X; Ma J; Han JD; Wang N; Chen YG
    Microvasc Res; 2006 Jan; 71(1):12-9. PubMed ID: 16405919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ALK2 functions as a BMP type I receptor and induces Indian hedgehog in chondrocytes during skeletal development.
    Zhang D; Schwarz EM; Rosier RN; Zuscik MJ; Puzas JE; O'Keefe RJ
    J Bone Miner Res; 2003 Sep; 18(9):1593-604. PubMed ID: 12968668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of heart valve lesions by small-molecule ALK5 inhibitors.
    Anderton MJ; Mellor HR; Bell A; Sadler C; Pass M; Powell S; Steele SJ; Roberts RR; Heier A
    Toxicol Pathol; 2011 Oct; 39(6):916-24. PubMed ID: 21859884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ALK1 opposes ALK5/Smad3 signaling and expression of extracellular matrix components in human chondrocytes.
    Finnson KW; Parker WL; ten Dijke P; Thorikay M; Philip A
    J Bone Miner Res; 2008 Jun; 23(6):896-906. PubMed ID: 18333754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of TGF-beta signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine-induced liver fibrosis.
    de Gouville AC; Boullay V; Krysa G; Pilot J; Brusq JM; Loriolle F; Gauthier JM; Papworth SA; Laroze A; Gellibert F; Huet S
    Br J Pharmacol; 2005 May; 145(2):166-77. PubMed ID: 15723089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microarray analysis of proliferative and hypertrophic growth plate zones identifies differentiation markers and signal pathways.
    Wang Y; Middleton F; Horton JA; Reichel L; Farnum CE; Damron TA
    Bone; 2004 Dec; 35(6):1273-93. PubMed ID: 15589209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of 4-{4-[3-(pyridin-2-yl)-1H-pyrazol-4-yl]pyridin-2-yl}-N-(tetrahydro-2H- pyran-4-yl)benzamide (GW788388): a potent, selective, and orally active transforming growth factor-beta type I receptor inhibitor.
    Gellibert F; de Gouville AC; Woolven J; Mathews N; Nguyen VL; Bertho-Ruault C; Patikis A; Grygielko ET; Laping NJ; Huet S
    J Med Chem; 2006 Apr; 49(7):2210-21. PubMed ID: 16570917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta induces expression of vascular endothelial growth factor in human retinal pigment epithelial cells: involvement of mitogen-activated protein kinases.
    Nagineni CN; Samuel W; Nagineni S; Pardhasaradhi K; Wiggert B; Detrick B; Hooks JJ
    J Cell Physiol; 2003 Dec; 197(3):453-62. PubMed ID: 14566975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta type 1 receptor (ALK5) and Smad proteins mediate TIMP-1 and collagen synthesis in experimental intestinal fibrosis.
    Medina C; Santos-Martinez MJ; Santana A; Paz-Cabrera MC; Johnston MJ; Mourelle M; Salas A; Guarner F
    J Pathol; 2011 Aug; 224(4):461-72. PubMed ID: 21465486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of ALK5 as a new approach to treat liver fibrotic diseases.
    de Gouville AC; Huet S
    Drug News Perspect; 2006 Mar; 19(2):85-90. PubMed ID: 16628263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive transforming growth factor beta1-induced lung fibrosis is blocked by an orally active ALK5 kinase inhibitor.
    Bonniaud P; Margetts PJ; Kolb M; Schroeder JA; Kapoun AM; Damm D; Murphy A; Chakravarty S; Dugar S; Higgins L; Protter AA; Gauldie J
    Am J Respir Crit Care Med; 2005 Apr; 171(8):889-98. PubMed ID: 15563636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The perichondrium plays an important role in mediating the effects of TGF-beta1 on endochondral bone formation.
    Alvarez J; Horton J; Sohn P; Serra R
    Dev Dyn; 2001 Jul; 221(3):311-21. PubMed ID: 11458391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of gene markers of fibrosis with a novel inhibitor of transforming growth factor-beta type I receptor kinase in puromycin-induced nephritis.
    Grygielko ET; Martin WM; Tweed C; Thornton P; Harling J; Brooks DP; Laping NJ
    J Pharmacol Exp Ther; 2005 Jun; 313(3):943-51. PubMed ID: 15769863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-{beta}1 activates two distinct type I receptors in neurons: implications for neuronal NF-{kappa}B signaling.
    König HG; Kögel D; Rami A; Prehn JH
    J Cell Biol; 2005 Mar; 168(7):1077-86. PubMed ID: 15781474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.